Mistakes in the diagnosis and treatment of atopic dermatitis

被引:0
|
作者
Marko, Monika [1 ]
Pawliczak, Rafal [1 ,2 ]
机构
[1] Uniwersytet Med Lodzi, Wydzial Lekarski, Zaklad Immunopatol, Oddzial Nauk Biomed, Lodz, Poland
[2] Uniwersytet Med Lodzi, Zaklad Immunopatol, Wydzial Lekarski, Oddzial Nauk Biomed, ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
关键词
atopic dermatitis; diagnosis; treatment; mistakes; obstacles; TOPICAL CORTICOSTEROID PHOBIA; EPIDEMIOLOGY; ECZEMA; PATHOPHYSIOLOGY; SEVERITY; AREA;
D O I
10.5114/pja.2024.135451
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Atopic dermatitis (AD) is defined as a chronic inflammatory dermatosis that is characterized by periods of remission and relapse. Over the last decade, the incidence of AD has increased in industrialized countries, becoming a socio-economic burden because it affects not only patients but also reduces the quality of life of the entire family. Despite the constant expansion and systematization of knowledge, AD is a disease about which many myths circulate. The divergent information concerns primarily the causes and course of AD, as well as diagnosis and therapy. It is easy to make mistakes during the diagnosis and treatment of AD due to the complex clinical picture of the disease and the diversity of phenotypes. Obstacles can also be encountered during differential diagnosis. Because AD mainly affects children, the problem of diagnosis and therapy concerns primarily general practitioners (GPs) and pediatricians. This review aims to identify the most common incorrect decisions made during cooperation with a patient suffering from AD. We emphasized that current diagnostic and therapeutic guidelines are recommended. Therefore, based on European Guideline EuroGuiDerm, we indicate what is inappropriate in treating AD and highlight the most important aspects of this disease management that practitioners should remember. We answer when a mistake may occur in diagnosing AD and what should be remembered when choosing therapy. We also point out that conversation with patients and their caregivers is an element that largely influences the effective treatment of AD.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [31] ATOPIC-DERMATITIS - AN OBVIOUS DIAGNOSIS
    ARCHER, CB
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1986, 11 (06) : 560 - 563
  • [32] Diagnosis and Management of Atopic Dermatitis: A Review
    Maliyar, Khalad
    Sibbald, Cathryn
    Pope, Elena
    Sibbald, R. Gary
    ADVANCES IN SKIN & WOUND CARE, 2018, 31 (12) : 538 - 550
  • [33] The millennium criteria for the diagnosis of atopic dermatitis
    Bos, JD
    Van Leent, EJM
    Smitt, JHS
    EXPERIMENTAL DERMATOLOGY, 1998, 7 (04) : 132 - 138
  • [34] Atopic dermatitis - complications and differential diagnosis
    Abeck, D.
    ALLERGOLOGIE, 2010, 33 (04) : 142 - 146
  • [35] CORTISONE TREATMENT IN ATOPIC DERMATITIS
    PODOLSKY, WG
    NEW YORK STATE JOURNAL OF MEDICINE, 1952, 52 (09) : 1180 - 1180
  • [36] Immunology and Treatment of Atopic Dermatitis
    Jonathan M. Spergel
    American Journal of Clinical Dermatology, 2008, 9 : 233 - 244
  • [37] Baricitinib for the treatment of atopic dermatitis
    Melo, Amelia
    Manuel Carrascosa, Jose
    Torres, Tiago
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2404 - 2413
  • [38] Dupilumab for treatment of atopic dermatitis
    Seegraeber, Marlene
    Srour, Jerome
    Walter, Alexandra
    Knop, Macarena
    Wollenberg, Andreas
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 467 - 474
  • [39] Treatment principles of atopic dermatitis
    Thestrup-Pedersen, K
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2002, 16 (01) : 1 - 9
  • [40] Omalizumab for the Treatment of Atopic Dermatitis
    Fernandez-Anton Martinez, M. C.
    Leis-Dosil, V.
    Alfageme-Roldan, F.
    Paravisini, A.
    Sanchez-Ramon, S.
    Suarez Fernandez, R.
    ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 (07): : 624 - 628